Effects of Antibiotics on Gut Microbiota
The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
The gut microbiota influences essential human functions including digestion, energy metabolism, and inflammation by modulating multiple endocrine, neural, and immune pathways of the host. Its composition and complexity varies markedly across individuals and across different sites of the gut, but provides a certain level of resilience against external perturbation. Short-term antibiotic treatment is able to shift the gut microbiota to long-term alternative dysbiotic states, which may promote the development and aggravation of disease. Common features of post-antibiotic dysbiosis include a loss of taxonomic and functional diversity combined with reduced colonization resistance against invading pathogens, which harbors the danger of antimicrobial resistance. This review summarizes the antibiotic-related changes of the gut microbiota and potential consequences in health and disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antibiotics (ATB) alter gut microbiota diversity and composition leading to dysbiosis, which may affect effectiveness of ICI.”
From Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer (2018) · cites this paper as [14]
In the citing paper
“16S ribosomal RNA sequencing of gene amplicons of patients' feces revealed that microbiota returns to its baseline within 1-3 months after ATB discontinuation.”
From Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer (2018) · cites this paper as [14]
In the citing paper
“However, some bacteria may take years to fully recover [14,20].”
From Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer (2018) · cites this paper as [14]
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785
Diversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Human gut microbiome viewed across age and geography
Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., Magris, M., Hidalgo, G., Baldassano, R. N., Anokhin, A. P., et al. (2012) · Nature · doi:10.1038/nature11053 · Cited by 7,815
Enterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Diversity, stability and resilience of the human gut microbiota
Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K., & Knight, R. (2012) · Nature · doi:10.1038/nature11550 · Cited by 5,533
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819
Host-gut microbiota metabolic interactions
Nicholson, J. K., Holmes, E., Kinross, J., Burcelin, R., Gibson, G., Jia, W., & Pettersson, S. (2012) · Science · doi:10.1126/science.1223813 · Cited by 4,760
Cited by
Vagus Nerve as Modulator of the Brain–Gut Axis in Psychiatric and Inflammatory Disorders
Breit, S., Kupferberg, A., Rogler, G., & Hasler, G. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00044 · Cited by 1,189
“There is growing evidence that nutritional components, such as probiotics (122, 123), gluten (124), as well as drugs, such as anti-oxidative agents (125) and antibiotics (126), have a high impact on vagus nerve activity through the interaction with the gut microbiota and that this effect varies greatly between individ…”
BackgroundAntibiotics as Major Disruptors of Gut Microbiota
Ramirez, J., Guarner, F., Bustos Fernandez, L., Maruy, A., Sdepanian, V. L., & Cohen, H. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.572912 · Cited by 898
“Antibiotic treatment reduces the overall diversity of gut microbiota species, including loss of some important taxa, which causes metabolic shifts, increases gut susceptibility to colonization, and stimulates the development of bacterial antibiotic resistance (Lange et al., 2016).”
BackgroundDerosa, L., Hellmann, M. D., Spaziano, M., Halpenny, D., Fidelle, M., Rizvi, H., Long, N., Plodkowski, A. J., Arbour, K. C., Chaft, J. E., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy103 · Cited by 908
Neutrophil Extracellular Traps and Its Implications in Inflammation: An Overview
Delgado-Rizo, V., Martínez-Guzmán, M. A., Iñiguez-Gutierrez, L., García-Orozco, A., Alvarado-Navarro, A., & Fafutis-Morris, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00081 · Cited by 686
“Clostridium difficile Clostridium difficile causes diarrhea and pseudomembranous colitis in humans, generally due to the abuse of antibiotics (79) that severely harm the host resident microbiota, leading to dysbiosis (80).”
BackgroundEpidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults
Stoffel, E. M., & Murphy, C. C. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.07.055 · Cited by 637
Effects of environmental pollutants on gut microbiota
Jin, Y., Wu, S., Zeng, Z., & Fu, Z. (2017) · Environmental Pollution · doi:10.1016/j.envpol.2016.11.045 · Cited by 660
Probiotics, prebiotics, and postbiotics in health and disease
Ji, J., Jin, W., Liu, S., Jiao, Z., & Li, X. (2023) · MedComm · doi:10.1002/mco2.420 · Cited by 384
“79,80 Emerging research suggests that the influence of medicines on gut microbiota is not solely limited to antibiotics.”
BackgroundGut microbiome and its role in colorectal cancer
Rebersek, M. (2021) · BMC Cancer · doi:10.1186/s12885-021-09054-2 · Cited by 355
Luo, T., Wang, C., Pan, Z., Jin, C., Fu, Z., & Jin, Y. (2019) · Environmental Science & Technology · doi:10.1021/acs.est.9b03191 · Cited by 388
Mullish, B. H., Quraishi, M. N., Segal, J. P., McCune, V. L., Baxter, M., Marsden, G. L., Moore, D. J., Colville, A., Bhala, N., Iqbal, T. H., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-316818 · Cited by 332
Antibiotic use and microbiome function
Ferrer, M., Méndez-García, C., Rojo, D., Barbas, C., & Moya, A. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.09.007 · Cited by 299
Bacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota
Anjana, & Tiwari, S. K. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.851140 · Cited by 264
“The perturbation in the commensal gut microbial flora causes dysbiosis, which happens due to several factors like imbalanced diet, infection, or the use of antibiotics, which can cause a long-term shift in the gut commensal microflora, promoting a large number of deadly diseases (Lange et al., 2016).”
BackgroundAntimicrobial Resistance and Its Spread Is a Global Threat
Aljeldah, M. M. (2022) · Antibiotics · doi:10.3390/antibiotics11081082 · Cited by 247
“Apart from AMR, studies have also implicated impacts of antibiotics on diseases, including obesity, cancer, and inflammatory bowel disease [23].”
BackgroundKim, Y.-K., & Shin, C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666170915141036 · Cited by 271
“Even the short-term use of antibiotics can lead to long-term dysbiosis, inducing accelerated maturation and exacerbation of diseases [21].”
BackgroundAntibiotics in early life: dysbiosis and the damage done
Neuman, H., Forsythe, P., Uzan, A., Avni, O., & Koren, O. (2018) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuy018 · Cited by 259
Crosstalk between Gut Microbiota and Host Immunity: Impact on Inflammation and Immunotherapy
Campbell, C., Kandalgaonkar, M. R., Golonka, R. M., Yeoh, B. S., Vijay-Kumar, M., & Saha, P. (2023) · Biomedicines · doi:10.3390/biomedicines11020294 · Cited by 243
“Antibiotics can have several direct and indirect negative impacts on adult human health, such as the development of antibiotic resistance for select microbial species and the loss of beneficial taxa [140].”
BackgroundAkkermansia muciniphila: biology, microbial ecology, host interactions and therapeutic potential
Ioannou, A., Berkhout, M. D., Geerlings, S. Y., & Belzer, C. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01106-1 · Cited by 221
Antibiotic Discovery and Resistance: The Chase and the Race
Iskandar, K., Murugaiyan, J., Hammoudi Halat, D., Hage, S. E., Chibabhai, V., Adukkadukkam, S., Roques, C., Molinier, L., Salameh, P., & Van Dongen, M. (2022) · Antibiotics · doi:10.3390/antibiotics11020182 · Cited by 223
Gut microbiota changes in the extreme decades of human life: a focus on centenarians
Santoro, A., Ostan, R., Candela, M., Biagi, E., Brigidi, P., Capri, M., & Franceschi, C. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2674-y · Cited by 250
Update of probiotics in human world: A nonstop source of benefactions till the end of time
Zommiti, M., Feuilloley, M. G. J., & Connil, N. (2020) · Microorganisms · doi:10.3390/microorganisms8121907 · Cited by 225
Antibiotic-induced gut dysbiosis and barrier disruption and the potential protective strategies
Duan, H., Yu, L., Tian, F., Zhai, Q., Fan, L., & Chen, W. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1843396 · Cited by 207
Wang, Y., Li, X., Ge, T., Xiao, Y., Liao, Y., Cui, Y., Zhang, Y., Ho, W., Yu, G., & Zhang, T. (2016) · Medicine · doi:10.1097/md.0000000000004509 · Cited by 204
“Inappropriate and wide use of antibiotics may lead to the development of bacterial resistance and disturb the normal balance of human microbiota, facilitating the pathogen colonization and reducing availability of vaccines for viruses.([7,8]) Economic impact of RTIs is also significant among countries.”
Wang, S.-Z., Yu, Y.-J., & Adeli, K. (2020) · Microorganisms · doi:10.3390/microorganisms8040527 · Cited by 207
Long-term use of antibiotics and risk of colorectal adenoma
Cao, Y., Wu, K., Mehta, R., Drew, D. A., Song, M., Lochhead, P., Nguyen, L. H., Izard, J., Fuchs, C. S., Garrett, W. S., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-313413 · Cited by 192
Factors Influencing Equine Gut Microbiota: Current Knowledge
Garber, A., Hastie, P. M., & Murray, J. (2020) · Journal of Equine Veterinary Science · doi:10.1016/j.jevs.2020.102943 · Cited by 250
“In human-related research common sequelae of antibiotic-induced dysbiosis include reduced microbial diversity and increased risk of development diseases associated with pathobionts [100].”
BackgroundElkrief, A., El Raichani, L., Richard, C., Messaoudene, M., Belkaid, W., Malo, J., Belanger, K., Miller, W., Jamal, R., Letarte, N., et al. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1568812 · Cited by 208
“In addition, the beneficial role of probiotics post-ATB remains controversial.(17) Interventions to promote microbiota recovery post-ATB should also be studied in randomized clinical studies.”
BackgroundDevelopment of the Pediatric Gut Microbiome: Impact on Health and Disease
Ihekweazu, F. D., & Versalovic, J. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.08.005 · Cited by 198
“These antibiotic-related changes included decreased taxonomic and functional diversity of the gut microbiome as well as a decreased colonization resistance against invading pathogens.(73) Additionally, Deneve et al(74) discovered that exposure to subinhibitory concentrations of certain antibiotics upregulated the expr…”
Tedijanto, C., Olesen, S. W., Grad, Y. H., & Lipsitch, M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810840115 · Cited by 199
“Direct evidence of selection on the gut normal flora by oral antibiotics has been reported (26).”
BackgroundAntibiotic-Induced Disruption of Gut Microbiota Alters Local Metabolomes and Immune Responses
Sun, L., Zhang, X., Zhang, Y., Zheng, K., Xiang, Q., Chen, N., Chen, Z., Zhang, N., Zhu, J., & He, Q. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00099 · Cited by 180
Impact of vaccines on antimicrobial resistance
Buchy, P., Ascioglu, S., Buisson, Y., Datta, S., Nissen, M., Tambyah, P. A., & Vong, S. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.10.005 · Cited by 165
The Excellent Online Instructor: Strategies for Professional Development
Palloff, R. M., & Pratt, K. (2011) · Cited by 246
Phage therapy: A targeted approach to overcoming antibiotic resistance
Olawade, D. B., Fapohunda, O., Egbon, E., Ebiesuwa, O. A., Usman, S. O., Faronbi, A. O., & Fidelis, S. C. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.107088 · Cited by 186
Antibiotics and the gut microbiome: Understanding the impact on human health
Lathakumari, R. H., Vajravelu, L. K., Satheesan, A., Ravi, S., & Thulukanam, J. (2024) · Medicine in Microecology · doi:10.1016/j.medmic.2024.100106 · Cited by 147
Zhao, S., Gao, G., Li, W., Li, X., Zhao, C., Jiang, T., Jia, Y., He, Y., Li, A., Su, C., et al. (2019) · Lung Cancer · doi:10.1016/j.lungcan.2019.01.017 · Cited by 164
The varying effects of antibiotics on gut microbiota
Yang, L., Bajinka, O., Jarju, P. O., Tan, Y., Taal, A. M., & Özdemir, G. (2021) · AMB Express · doi:10.1186/s13568-021-01274-w · Cited by 169
“And hence it is imperative to be highly cautious when debilitation our intestinal microbiota with drugs of unknown consequences (Lange et al. 2016; Langdon et al. 2016).”
BackgroundA Gram-negative-selective antibiotic that spares the gut microbiome
Muñoz, K. A., Ulrich, R. J., Vasan, A. K., Sinclair, M., Wen, P., Holmes, J. R., Lee, H. Y., Hung, C., Fields, C. J., Tajkhorshid, E., et al. (2024) · Nature · doi:10.1038/s41586-024-07502-0 · Cited by 167
Fish disease and intestinal microbiota: A close and indivisible relationship
Medina‐Félix, D., Garibay-Valdéz, E., Vargas‐Albores, F., & Martínez‐Porchas, M. (2022) · Reviews in Aquaculture · doi:10.1111/raq.12762 · Cited by 162
Bacteroidetes Species Are Correlated with Disease Activity in Ulcerative Colitis
Nomura, K., Ishikawa, D., Okahara, K., Ito, S., Haga, K., Takahashi, M., Arakawa, A., Shibuya, T., Osada, T., Kuwahara-Arai, K., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081749 · Cited by 150
“Eligible patients were over 16 years of age and had not received antibiotics or topical steroids, which can influence the microbiome composition, within 3 months before fecal sample collection [23,24].”
BackgroundSafarchi, A., Al-Qadami, G. H., Tran, C. D., & Conlon, M. A. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1559521 · Cited by 158
“…of RM in individuals present a formidable challenge, primarily due to the absence of well-defined biomarkers and indices that could offer comprehensive insights into the microbial landscape before disturbance factors such as xenobiotics are encountered (Sommer et al., 2017; Lange et al., 2016).”
Cheng, H., Liu, J., Tan, Y., Feng, W., & Peng, C. Y. (2021) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2021.10.003 · Cited by 150
The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors
Minalyan, A., Gabrielyan, L., Scott, D., Jacobs, J., & Pisegna, J. R. (2017) · Current Gastroenterology Reports · doi:10.1007/s11894-017-0577-6 · Cited by 127
The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)
König, R. S., Albrich, W. C., Kahlert, C. R., Bahr, L. S., Löber, U., Vernazza, P., Scheibenbogen, C., & Forslund, S. K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.628741 · Cited by 148
Targeting gut microbiota for precision medicine: Focusing on the efficacy and toxicity of drugs
Feng, W., Liu, J., Ao, H., Yue, S., & Peng, C. (2020) · Theranostics · doi:10.7150/thno.47289 · Cited by 121
“For example, traditional antibiotics often cause long-term and widespread destruction of the gut microbiota composition and even lead to antibiotic resistance, which may further promote the development and aggravation of diseases [216].”
BackgroundLoss of microbial diversity and pathogen domination of the gut microbiota in critically ill patients
Ravi, A., Halstead, F. D., Bamford, A., Casey, A., Thomson, N. M., van Schaik, W., Snelson, C., Goulden, R., Foster-Nyarko, E., Savva, G. M., et al. (2019) · Microbial Genomics · doi:10.1099/mgen.0.000293 · Cited by 125
Dierikx, T. H., Visser, D. H., Benninga, M. A., van Kaam, A. H., de Boer, N. K. H., de Vries, R., Limbergen, J. V., & de Meij, T. G. J. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.002 · Cited by 139
Gudda, F. O., Waigi, M. G., Odinga, E. S., Yang, B., Carter, L., & Gao, Y. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.114752 · Cited by 125
Inchingolo, A. D., Malcangi, G., Semjonova, A., Inchingolo, A. M., Patano, A., Coloccia, G., Ceci, S., Marinelli, G., Pede, C. D., Ciocia, A. M., et al. (2022) · Children · doi:10.3390/children9071014 · Cited by 145
“Antibiotic usage may lead to bacterial resistance and disturb the normal microbiota balance, favoring pathogen colonization and decreasing viral vaccine accessibility [210,211].”
BackgroundHost and Microbiome Genome-Wide Association Studies: Current State and Challenges
Awany, D., Allali, I., Dalvie, S., Hemmings, S., Mwaikono, K. S., Thomford, N. E., Gomez, A., Mulder, N., & Chimusa, E. R. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2018.00637 · Cited by 109
“This dysbiosis state is characterized by a loss of taxonomic and functional diversity, which may shift the host’s metabolic capacity and reduce the colonization resistance against invading pathogens (Langdon et al., 2016; Lange et al., 2016).”
BackgroundWei, S., Mortensen, M. S., Stokholm, J., Brejnrod, A., Thorsen, J., Rasmussen, M. A., Trivedi, U., Bisgaard, H. F., & Sørensen, S. J. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.035 · Cited by 117
“Current guidelines discourage the use of antibiotics during asthma-like episodes in early life due to lack of evidence of severe bacterial infections as main episode triggers [3], and adverse effects on the colonizing microbiota [43,44].”
BackgroundFan, Y., Han, W., Zhan, G., Li, S., Jiang, X., Wang, L., Xiang, S., Zhu, B., Yang, L., Luo, A., et al. (2019) · Aging · doi:10.18632/aging.102469 · Cited by 124
“In vehicletreated mice, 19 bacteria were significantly decreased, suggesting a deleterious effect induced by antibiotic treatment [43].”
BackgroundChang, X., Wang, X., Feng, J., Su, X., Liang, J., Li, H., & Zhang, J. (2019) · Environmental Pollution · doi:10.1016/j.envpol.2019.113846 · Cited by 170
Cellular and Molecular Mechanisms Mediating Methylmercury Neurotoxicity and Neuroinflammation
Novo, J. P., Martins, B., Raposo, R. D. S., Pereira, F. C., Oriá, R. B., Malva, J. O., & Ribeiro, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063101 · Cited by 116
“Additionally, the use of antibiotics could be related to MeHg decomposition due to its direct effect on microbiota [79].”
He, S., Wang, Q., Li, S., Ran, C., Guo, X., Zhang, Z., & Zhou, Z. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-9072-6 · Cited by 115
Chang, X., Li, H., Feng, J., Chen, Y., Nie, G., & Zhang, J. (2018) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2018.12.066 · Cited by 107
Ouaknine Krief, J., Helly de Tauriers, P., Dumenil, C., Neveux, N., Dumoulin, J., Giraud, V., Labrune, S., Tisserand, J., Julie, C., Emile, J.-F., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0658-1 · Cited by 99
Metabolic Adaptations to Infections at the Organismal Level
Troha, K., & Ayres, J. S. (2020) · Trends in Immunology · doi:10.1016/j.it.2019.12.001 · Cited by 97
“It is well established that the widespread overuse of antibiotics decimates intestinal microbial communities, and this has been associated with increased susceptibility to diverse pathogens (27).”
BackgroundEffect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma
Lalani, A.-K. A., Xie, W., Braun, D. A., Kaymakcalan, M., Bossé, D., Steinharter, J. A., Martini, D. J., Simantov, R., Lin, X., Wei, X. X., et al. (2020) · European Urology Oncology · doi:10.1016/j.euo.2019.09.001 · Cited by 100
Ng, Q. X., Lim, Y. L., Yaow, C. Y. L., Ng, W., Thumboo, J., & Liew, T. M. (2023) · Nutrients · doi:10.3390/nu15061351 · Cited by 107
Intestinal microbiota and antibiotic resistance: Perspectives and solutions
Casals‐Pascual, C., Vergara, A., & Vilà, J. (2018) · Human Microbiome Journal · doi:10.1016/j.humic.2018.05.002 · Cited by 105
“[2,25,26]: class of antibiotic, pharmacokinetics, pharmacodynamics, range of action, dosage, duration, and administration route.”
BackgroundTMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review
Ye, Z., Lulu, C., Xiangchang, Z., Fang, Q., Binjie, Z., Chunyang, L., Rao, T., & Dongsheng, O. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.929262 · Cited by 104
“Although it is unclear whether dysbiosis leads to the increase of TMAO production in CKD patients, it may lead to more serious consequences, such as impaired intestinal mucosal barrier, increased intestinal inflammation (Lange et al., 2016; Vaziri et al., 2016; Velasquez et al., 2016; Andersen et al., 2017).”
BackgroundChen, X., Pan, S., Li, F., Xu, X., & Hua, X. (2022) · Biomolecules · doi:10.3390/biom12121871 · Cited by 100
“Moreover, as a very important part of the host, intestinal microbiota and its metabolites are involved in several physiological functions of the host by regulating various endocrine, neural, and immune pathways, including digestion, energy metabolism, and inflammation [2], thus playing remarkable roles in maintaining…”
BackgroundPeng, C., Xu, X., Li, Y., Li, X., Yang, X., Chen, H., Zhu, Y., Lü, N., & He, C. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-0281-3 · Cited by 96
Chen, P., Chen, X., Hao, L., Du, P., Li, C., Han, H., Xu, H., & Liu, L. (2021) · Food Chemistry · doi:10.1016/j.foodchem.2021.130233 · Cited by 88
Pan, L., Yu, H., Fu, J., Hu, J., Xu, H. X., Zhang, Z., Bu, M.-M., Yang, X., Zhang, H., Lu, J., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.12.010 · Cited by 92
Mokkala, K., Houttu, N., Cansev, T., & Laitinen, K. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.05.003 · Cited by 87
Giordan, Q., Salleron, J., Vallance, C., Moriana, C., & Clément-Duchêne, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.716317 · Cited by 84
“ATB and PPI Exposure Previous studies have shown that alteration of intestinal microbiota by ATB occurs within two months after ATB exposure (17, 18), while PPI treatment leads to dysbiosis after a continuous administration of 4 weeks (19).”
ResultMizutani, T., Ishizaka, A., Koga, M., Ikeuchi, K., Saito, M., Adachi, E., Yamayoshi, S., Iwatsuki‐Horimoto, K., Yasuhara, A., Kiyono, H., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01689-21 · Cited by 87
“Because antibiotic use is known to alter the profile of the gut microbiota (15), we examined this effect.”
BackgroundObianwuna, U. E., Kalu, N. A., Wang, J., Zhang, H., Qi, G., Qiu, K., & Wu, S. (2023) · Antioxidants · doi:10.3390/antiox12040911 · Cited by 90
Approach to the diagnosis and management of dysbiosis
Alagiakrishnan, K., Morgadinho, J., & Halverson, T. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1330903 · Cited by 91
“…diversity of gut microbiota species, which leads to metabolic shifts, increases gut colonization, which can lead to bacterial antibiotic resistance (111– 113) In humans antibiotic use is associated with Antibiotic-Associated Diarrhea, C. difficile -associated Diarrhea, Helicobacter Pylori…”
BackgroundDietary Gluten as a Conditioning Factor of the Gut Microbiota in Celiac Disease
Bascuñán, K. A., Araya, M., Roncoroni, L., Doneda, L., & Elli, L. (2019) · Advances in Nutrition · doi:10.1093/advances/nmz080 · Cited by 87
“, because of inflammatory conditions or use of antibiotics) alters the host’s general homeostasis (70), leads to dysbiosis, and potentially to some intestinal and extraintestinal diseases (71–73).”
BackgroundMullish, B. H., Quraishi, M. N., Segal, J. P., McCune, V. L., Baxter, M., Marsden, G. L., Moore, D., Colville, A., Bhala, N., Iqbal, T. H., et al. (2018) · Journal of Hospital Infection · doi:10.1016/j.jhin.2018.07.037 · Cited by 79
The oral microbiome in autoimmune diseases: friend or foe?
Huang, X., Huang, X., Huang, Y., Zheng, J., Ye, L., Mai, Z., Zhao, X., Cui, L., & Huang, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03995-x · Cited by 83
The role of gut microbiota in Clostridium difficile infection
Samarkos, M., Mastrogianni, E., & Kampouropoulou, O. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.02.006 · Cited by 75
Effects of Schisandra chinensis polysaccharides on rats with antibiotic-associated diarrhea
Qi, Y., Chen, L., Gao, K., Shao, Z., Huo, X., Mei, H., Liu, S., Sun, Y., & Li, S. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.11.250 · Cited by 81
Drug combinations targeting antibiotic resistance
Bognár, B., Spohn, R., & Lázár, V. (2024) · npj Antimicrobials and Resistance · doi:10.1038/s44259-024-00047-2 · Cited by 82
The Role of Gut Microbiota and Leaky Gut in the Pathogenesis of Food Allergy
Poto, R., Fusco, W., Rinninella, E., Cintoni, M., Kaitsas, F., Raoul, P. C., Caruso, C., Mele, M. C., Varricchi, G., Gasbarrini, A., et al. (2023) · Nutrients · doi:10.3390/nu16010092 · Cited by 81
Kim, H., Lee, J. E., Hong, S. H., Lee, M. A., Kang, J. H., & Kim, I.-H. (2019) · BMC Cancer · doi:10.1186/s12885-019-6267-z · Cited by 72
Ahn, J.-W., Lee, S., Kim, B., Nam, M. H., Ahn, Y. G., Park, Y. M., Jeong, S., Park, M. J., Song, K. B., Lee, S., et al. (2021) · Pediatric Allergy and Immunology · doi:10.1111/pai.13678 · Cited by 81
Vliex, L. M. M., Penders, J., Nauta, A., Zoetendal, E. G., & Blaak, E. E. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00966-0 · Cited by 75
“Microbial dysbiosis can culminate in detrimental health effects for the host, such as weight gain and the development of insulin resistance, given that the gut microbiome affects different organs in the body via multiple mechanisms 33,34 .”
Feng, L., Zhou, N., Li, Z., Fu, D., Guo, Y., Gao, X., & Liu, X. (2021) · The FASEB Journal · doi:10.1096/fj.202101088rrr · Cited by 72
Commensal-derived metabolites govern Vibrio cholerae pathogenesis in host intestine
You, J. S., Yong, J. H., Kim, G. H., Moon, S., Nam, K. T., Ryu, J. H., Yoon, M. Y., & Yoon, S. S. (2019) · Microbiome · doi:10.1186/s40168-019-0746-y · Cited by 77
Goff, D. A., Mangino, J. E., Glassman, A. H., Goff, D. W., Larsen, P. E., & Scheetz, R. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1118 · Cited by 75
Gut permeability and depressive symptom severity in unmedicated adolescents
Calarge, C. A., Devaraj, S., & Shulman, R. J. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.12.077 · Cited by 69
Sippola, S., Grönroos, J., Sallinen, V. J., Rautio, T., Nordström, P., Rantanen, T. K., Hurme, S. A. M., Leppäniemi, A. K., Meriläinen, S. A., Laukkarinen, J., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-023623 · Cited by 75
“Additionally, antimicrobials are known to decrease the diversity of the gut microbiota, richness and species variation and cause perturbation of its overall balance and even a short-term antimicrobial treatment has a longterm impact on the gut microbiota composition underlining the importance of evaluating both short-…”
BackgroundYu, F., Han, W., Zhan, G., Li, S., Xiang, S., Zhu, B., Jiang, X., Yang, L., Luo, A., Hua, F., et al. (2019) · Aging · doi:10.18632/aging.101978 · Cited by 65
“In addition, the levels of 21 bacteria were significantly altered in vehicle-treated mice, suggesting the effects of antibiotic treatment [35].”
BackgroundSchett, A., Rothschild, S. I., Fontecedro, A. C., Krähenbühl, S., Früh, M., Schmid, S., Driessen, C., & Joerger, M. (2019) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-019-03993-1 · Cited by 67
Grange, A. G., Carratalà, J., Eliakim‐Raz, N., Shaw, E., Wiegand, I., Vallejo‐Torres, L., Gorostiza, A., Vigo, J., Stephen Morris, A., Stoddart, M., et al. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s185753 · Cited by 63
“ments.(29) The indication of steroids and antibiotics should be carefully evaluated in every patient, given the high risk of P.”
BackgroundSelvamani, S., Mehta, V. K., Enshasy, H. A. E., Thevarajoo, S., Adawi, H. E., Zeini, I. M., Pham, K., Varzakas, T. H., & Abomoelak, B. (2022) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2022.02.044 · Cited by 66
Sardarni, U. K., Shet, A., Rajnala, N., Gopalan, B. P., Moar, P., Himanshu, D., Singh, B. P., Chaturvedi, R., & Tandon, R. (2018) · Scientific Reports · doi:10.1038/s41598-018-35877-4 · Cited by 65
The Case against Antibiotics and for Anti-Virulence Therapeutics
Hotinger, J. A., Morris, S. T., & May, A. E. (2021) · Microorganisms · doi:10.3390/microorganisms9102049 · Cited by 64
“The importance of these commensals in preventing secondary infection and disease is through simple competition as well as their assistance in host metabolism [31,84].”
BackgroundAntibiotic Resistance and Microbiota Response
Santacroce, L., Domenico, M. D., Montagnani, M., & Jirillo, E. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612829666221219093450 · Cited by 63
Tsitko, I. V., Wiik-Miettinen, F., Mattila, O., Rosa‐Sibakov, N., Seppänen‐Laakso, T., Maukonen, J., Nordlund, E., & Saarela, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081925 · Cited by 64
Long-term effects of antimicrobial drugs on the composition of the human gut microbiota
Mulder, M., Radjabzadeh, D., Jong, J. C. K., Uitterlinden, A. G., Kraaij, R., Stricker, B. H. C., & Verbon, A. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1791677 · Cited by 63
Characterization, health benefits and applications of fruits and vegetable probiotics
James, A., & Wang, Y. (2019) · CyTA - Journal of Food · doi:10.1080/19476337.2019.1652693 · Cited by 67
16S rRNA gene sequencing of rectal swab in patients affected by COVID-19
Mazzarelli, A., Giancola, M. L., Farina, A., Marchioni, L., Rueca, M., Gruber, C. E. M., Bartolini, B., Bartoli, T. A., Maffongelli, G., Capobianchi, M. R., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247041 · Cited by 58
“As for gut microbiota, antibiotics use can obviously determine a further loss of heterogeneity and composition, leading to down regulation of beneficial symbionts and exacerbation of gut dysbiosis, and for this reason the avoidance of unnecessary antibiotics use in the treatment of viral pneumonia is strongly suggeste…”
BackgroundGong, X., Xiong, L., Bi, C., & Zhang, B. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153582 · Cited by 56
Gut Microbiome as a Target of Intervention in Inflammatory Bowel Disease Pathogenesis and Therapy
Hetta, H. F., Ramadan, Y. N., Alharbi, A. A., Alsharif, S. M., Alkindy, T. T., Alkhamali, A., Albalawi, A. S., & El‐Amin, H. (2024) · Immuno · doi:10.3390/immuno4040026 · Cited by 57
“Probiotics are live bacteria that promote health when taken in sufficient doses.”
BackgroundSignificance of Gut Microbiota and Short-Chain Fatty Acids in Heart Failure
Zhao, P., Zhao, S., Tian, J., & Liu, X. (2022) · Nutrients · doi:10.3390/nu14183758 · Cited by 57
Waitzberg, D. L., Guarner, F., Hojsak, I., Ianiro, G., Polk, D. B., & Sokol, H. (2024) · Advances in Therapy · doi:10.1007/s12325-024-02783-3 · Cited by 56
Clostridioides difficile and Gut Microbiota: From Colonization to Infection and Treatment
Spigaglia, P. (2024) · Pathogens · doi:10.3390/pathogens13080646 · Cited by 60
“The excessive/wrong use of antibiotics, particularly those with a broad spectrum of action, represents the main risk for CDI, reducing the gut microbiota’s diversity and increasing gut colonization [97–99].”
Background
Metadata
- Authors
- Lange, K., Buerger, M., Stallmach, A., & Bruns, T.
- Affiliations
- Jena University Hospital (DE)
- Venue
- Digestive Diseases
- Publisher
- S. Karger AG
- Published
- 2016
- Volume
- 34
- Issue
- 3
- Pages
- 260-268
- ISSN
- 0257-2753 (ISSN-L)
- 1421-9875
- OpenAlex
- W2320251182
- Cited by
- 607
- References
- 101
- Citations by year
- 2026: 36 · 2025: 51 · 2024: 92 · 2023: 96 · 2022: 99 · 2021: 79 · 2020: 48 · 2019: 46 · 2018: 33 · 2017: 19 · 2016: 7
- FWCI
- 3.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Digestive Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- antibiotics, gut microbiota, dysbiosis, colonization resistance, antimicrobial resistance, microbial diversity, host-microbe interactions, energy metabolism, inflammation, disease susceptibility
- MeSH terms
- Gastrointestinal Microbiome, Anti-Bacterial Agents, Humans, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.